About 2% of global population suffers from OCD, of which only about 10% are receiving treatment
Investigational SaMD for contamination OCD*
*Obsessive Compulsive Disorder
Among CBT*, ERP** is first-line treatment for OCD, however, only 50% experience an improvement in OCD symptoms and the dropout rate is about 25%
*Cognitive Behavioral Therapy
**Exposure and Response Prevention
OC Free™ not only improves the accessibility and effectiveness of existing OCD treatments, but enhances the QOL* of patients through digitalized ERP treatment
*Quality of Life
Domestic Pilot study....
US Pilot study
.....US Pivotal study
BIXINK strives to be a pioneer in developing Korea's first FDA-approved digital therapeutics, and is currently pursuing pilot study in the United States
l OC Free™ l
Computerized Behavioral Therapy Device for OCD
CAUTION: Investigational Device.
Limited by Federal law to investigational use.
*FDA Approval Target 2025
6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258, Republic of Korea